ArticlePoultry science2026
Inhibitory effect of transfer factor on infection with the novel variant strain of infectious bursal disease virus in chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The novel variant strain of infectious bursal disease virus (nVarIBDV) has emerged as one of the immunosuppressive viruses severely threatening the poultry industry. Even with the presence of certain levels of maternal antibodies in some flocks, infection with nVarIBDV cannot be prevented. Non-specific immunostimulants are wildely used in clinical practice to enhance the prevention and control of this disease. To explore the potential of chicken transfer factor (TF) in suppressing nVarIBDV infection,a total of 210 SPF chicks were randomly divided into 7 groups in this study. The nVarIBDV infection was administered at two different ages (7 and 14 days post-hatch), and the TF treatment was applied at two dosage levels: low dose (0.25 mL per chick) and high dose (0.5 mL per chick). Viral load of nVarIBDV was detected via qRT-PCR at various time points, and the intervention effect of TF on nVarIBDV infection was evaluated through dynamic monitoring of body weight and analysis of bursal organ development index. The results showed that SPF chicks were infected with nVarIBDV at different ages (7 days and 14 days) significantly suppressed body weight gain and induced bursal atrophy. The application of TF could effectively alleviate the nVarIBDV-induced growth retardation and bursal atrophy, while also markedly inhibiting viral replication in the bursa of Fabricius. Moreover, the inhibitory effect was positively correlated with the dosage of TF used. This study provides a new technical supplement for improving the prevention and control of nVarIBDV, while also offering valuable insights for research on antiviral immune regulation in poultry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.